Global Biologics Manufacturing Market 2018-2022: Market to Grow at a CAGR of 9.11% With Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co & Pfizer Dominating

DUBLIN, October 4, 2018 /PRNewswire/ --

The "Global Biologics Manufacturing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe. The report also includes a discussion of the Key vendors operating in this market.

According to the report, one driver influencing this market is the introduction of new biologic drugs for treating diseases. There is a growing demand for biologics for effective treatment of diseases as synthetic drugs have several limitations.

One trend affecting this market is the rise in partnerships between traditional biopharma companies and biotechnology start-ups. The significant growth of the biologics industry and biotech companies in the past few years has encouraged several major traditional biopharma companies to collaborate with biotechnology start-ups to develop novel biologics drugs.

Further, the report states that one challenge affecting this market is the high cost of branded drugs is deterring market growth. A key factor restraining the growth of the global biologics manufacturing market is the high cost of medication.

Key questions answered in this report

• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the Key vendors in this market space?
• What are the market opportunities and threats faced by the Key vendors?
• What are the strengths and weaknesses of the Key vendors?

Key vendors 

• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck & Co
• Pfizer

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE 

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING 

• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS 

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY 

• Segmentation by technology
• Comparison by technology
• In-house - Market size and forecast 2017-2022
• Outsourced - Market size and forecast 2017-2022
• Market opportunity by technology

PART 08: MARKET SEGMENTATION BY PRODUCT 

• Segmentation by product
• Comparison by product
• Biologics - Market size and forecast 2017-2022
• Biosimilars - Market size and forecast 2017-2022
• Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE 

• Geographical segmentation
• Regional comparison
• Americas - Market size and forecast 2017-2022
• EMEA - Market size and forecast 2017-2022
• APAC - Market size and forecast 2017-2022
• Key leading countries
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES 

• Market drivers
• Market challenges

PART 13: MARKET TRENDS 

• Rise in partnerships between traditional biopharma companies and biotechnology start-ups
• Growing outsourcing of biologics manufacturing
• Increase in FDA approvals for new biologics products

PART 14: VENDOR LANDSCAPE 

• Overview
• Landscape disruption
• Competitive scenario

PART 15: VENDOR ANALYSIS 

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson
• Merck & Co.
• Pfizer

PART 16: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/49wg3t/global_biologics?w=14

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716